Cisplatin/fluorouracilBone marrow suppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1596卷 / 1期

关键词：

D O I：

10.1007/s40278-016-16308-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[1] FluorouracilBone marrow suppression, pneumonia and sepsis: case report
Reactions Weekly, 2021, 1867 (1) : 183 - 183
[2] Cisplatin/docetaxel/fluorouracilBone-marrow failure syndrome: case report
Reactions Weekly, 2019, 1755 (1) : 89 - 89
[3] Cisplatin/etoposideBone marrow suppression: case report
Reactions Weekly, 2025, 2046 (1) : 111 - 111
[4] Cisplatin/paclitaxelBone marrow suppression: case report
Reactions Weekly, 2023, 1944 (1) : 203 - 203
[5] Cisplatin/etoposideBone marrow suppression: case report
Reactions Weekly, 2019, 1738 (1) : 82 - 82
[6] Cisplatin/gemcitabineBone marrow suppression leading to neutropenia: case report
Reactions Weekly, 2020, 1805 (1) : 87 - 87
[7] Cisplatin/vinorelbineBone marrow suppression and gastrointestinal reaction: case report
Reactions Weekly, 2017, 1680 (1) : 90 - 90
[8] Cisplatin/Gemcitabine/TislelizumabHyponatraemia and bone marrow suppression: case report
Reactions Weekly, 2025, 2047 (1) : 128 - 128
[9] Cisplatin/etoposideBone marrow suppression, gastrointestinal reactions and immunosuppression: case report
Reactions Weekly, 2025, 2046 (1) : 110 - 110
[10] Bevacizumab/cisplatin/pemetrexedBone marrow suppression, immunodeficiency and dysphagia: case report
Reactions Weekly, 2022, 1904 (1) : 120 - 120

← 1 2 3 4 5 →